Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor fredericamycin analogues developed at Biofrontera

Nov. 3, 2003

Abbott claims new Bcl-XL/Bcl-2 inhibitors and their use in cancer therapy

Nov. 3, 2003

Fast track designation for Tocosol Paclitaxel

Oct. 31, 2003

Oncolytics Biotech and NCI enter collaborative agreement for Reolysin

Oct. 31, 2003

New pyrrole-based photosensitizers and their use in cancer therapy

Oct. 31, 2003

Novel FTase inhibitors prepared and tested at Janssen

Oct. 31, 2003

Recombinant human angiostatin well tolerated in cancer patients

Oct. 31, 2003

Acceptable safety profile described for oral diflomotecan in solid tumors

Oct. 31, 2003

Targeted therapy of AML with anti-FLT3 antibody under evaluation

Oct. 30, 2003

Canadian approval for Gleevec for newly diagnosed Ph+ CML

Oct. 30, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...